Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEMDOC: Gemcitabine and Docetaxel in Recurrent/Metastatic SCCHN
NCT00248560Phase 2Completed
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Start
- Jan 2005
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, docetaxel in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Barbara Ann Karmanos Cancer Institute. Started Jan 2005; status: completed.
02
Drugs
gemcitabinedocetaxel
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00248560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00248560.